Skip to main content

Table 2 Univariate analysis of factors associated with 90-day readmission in veterans with IBD

From: Risk factors for 90-day readmission in veterans with inflammatory bowel disease—Does post-discharge follow-up matter?

Item No readmission 90-day readmission P value
Age (year, x ± s) 59.2 ± 15.6 61.4 ± 13.1 0.31
Male (n (%)) 138 (96.5) 59 (100) 0.15
Caucasian (n (%)) 128 (89.5) 57 (96.6) 0.10
History of psychiatric disorder (n (%)) 74 (51.7) 42 (71.2) 0.01
Type of IBD (n (%))    < 0.001
 Crohn’s disease 78 (54.5) 48 (81.4)  
 Ulcerative colitis 65 (45.5) 11 (18.6)  
Duration of IBD (year, median(IQR)) 16 (7-30) 16 (3-34) 0.84
History of bowel resection (n (%)) 95 (66.4) 39 (66.1) 0.96
IBD medication prior to admission (n (%))
 5-ASA 51 (35.7) 15 (25.4) 0.16
 Immunomodulator (AZA/6-MP or MTX) 29 (20.3) 15 (25.4) 0.42
 Anti-TNF 18 (12.6) 6 (10.2) 0.63
 Steroids 25 (17.5) 15 (25.4) 0.20
Psychiatric/pain medication prior to admission (n (%))
 Benzodiazepine 24 (16.8) 9 (15.3) 0.79
 Narcotics 57 (39.9) 28 (47.5) 0.32
 Antidepressant 47 (32.9) 33 (55.9) 0.002
Medication at discharge (n (%))
 Change in IBD medication at discharge 32 (22.4) 23 (39) 0.02
 Benzodiazepine at discharge 22 (15.4) 8 (13.6) 0.74
 Narcotics at discharge 75 (52.4) 29 (49.2) 0.67
 Discharge to home (n (%)) 135 (94.4) 51 (86.4) 0.06
Complication during hospitalization (n (%))
 Surgical procedures during admission 28 (19.6) 10 (16.9) 0.66
 ICU stay 6 (4.2) 3 (5.1) 0.78
 Nosocomial infection 6 (4.2) 2 (3.4) 0.79
 Venous thromboembolism 1 (0.7) 1 (1.7) 0.52
 Length of hospitalization (day, median (IQR)) 4 (2-6) 4 (2-8) 0.84
Follow-up after hospitalization (n (%))
 Mention of follow-up with PCP in discharge summary/nurse note 71 (49.7) 32 (54.2) 0.55
 Follow-up with PCP clinic within 90 days 74 (51.7) 16 (27.1) 0.001
 Mention of follow-up with GI in discharge summary/nurse note 67 (46.9) 31 (52.5) 0.46
 Follow-up in GI clinic within 90 days 67 (46.9) 18 (30.5) 0.03
  1. IBD inflammatory bowel disease, IQR interquartile range, PCP primary care physician, TNF tumor necrosis factor, ICU Intensive care unit, GI gastroenterologist